InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Nova Tina Susan, Présidente. Insider active across 3 companies, notably Arena Pharmaceuticals INC. Aggregated, 8 disclosures have been logged. History available since 11 June 2021. The latest transaction was filed on 6 February 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Nova Tina Susan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
5,663 shares@ US$27.8527.4% of flowCommonSEC:0001193125-26-041527:0
4,040 shares@ US$52.3257.5% of flowCommonSEC:0000950170-25-017893:0
2,465 shares@ US$65.9342.5% of flowCommonSEC:0000950170-24-014558:0
3,604 shares0Common StockSEC:0001209191-23-009725:0
17,776 sharesCommon StockSEC:0001628280-22-005918:0
56,546 shares0Common StockSEC:0001384101-22-000052:0
10,695 shares@ US$27.84100.0% of flowCommon StockSEC:0001384101-22-000038:0
3,067 shares0Common StockSEC:0001628280-21-012279:0
8 of 8 declarations
About Nova Tina Susan
Tina Susan Nova is the President and CLIA U.S. Operations Director at ARENA PHARMACEUTICALS INC and VERACYTE, INC. She oversees the operational and strategic activities of both companies, bringing her expertise in the life sciences field. Her role is essential in ensuring regulatory compliance and innovation in product development. Through her leadership, she contributes to the growth and success of the organizations.
